Table 6.
Treatment | Vaccine | Challenge | Age | vGlu, mg/dl | iGlu, mg/dl | TCO2, mmol/l | HCT, % | MDA, μM | HET | LYM | HET:LYM |
---|---|---|---|---|---|---|---|---|---|---|---|
Main effects | |||||||||||
− | 222.4 | 223.2 | 22.1 | 19.0 | 1.00 | 2,249.2 | 5,008.4 | 0.44 | |||
+ | 217.6 | 215.2 | 22.1 | 18.4 | 0.99 | 2,412.1 | 5,522.3 | 0.45 | |||
P < | NS | NS | NS | NS | NS | NS | NS | NS | |||
− | 221.7 | 222.4 | 21.9 | 18.9 | 0.99 | 2,432.0 | 5,445.0 | 0.44 | |||
+ | 218.4 | 216.0 | 22.3 | 18.5 | 0.99 | 2,229.3 | 5,085.8 | 0.45 | |||
P < | NS | NS | NS | NS | NS | NS | NS | NS | |||
6 | 215.6 | 212.4 | 20.7 | 15.1 | 1.47 | 417.7 | 1,997.2 | 0.24 | |||
8 | 201.2 | 202.6 | 20.3 | 16.5 | 1.14 | 583.7 | 2,161.3 | 0.25 | |||
13 | 223.2 | 227.6 | 22.1 | 18.9 | 1.22 | 4,461.1 | 4,580.3 | 0.99 | |||
20 | 218.8 | 217.4 | 21.5 | 19.6 | 0.94 | 2,436.2 | 8,541.5 | 0.30 | |||
27 | 233.6 | 230.2 | 24.1 | 21.7 | 0.78 | 2,355.0 | 8,106.6 | 0.30 | |||
34 | 227.8 | 225.0 | 24.0 | 20.5 | 0.42 | 3,730.3 | 6,205.4 | 0.60 | |||
P < | 0.05 | 0.05 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||
L < | 0.05 | 0.05 | 0.001 | 0.001 | 0.001 | 0.01 | 0.001 | 0.01 | |||
Q < | 0.05 | 0.05 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||
SEM | 12.94 | 13.83 | 1.26 | 1.33 | 0.166 | 668.73 | 722.50 | 0.102 | |||
Interaction terms | |||||||||||
Vaccine × challenge | NS | NS | NS | NS | NS | NS | NS | NS | |||
Vaccine × age | NS | NS | NS | NS | NS | NS | NS | NS | |||
Challenge × age | NS | NS | 0.05 | NS | NS | NS | NS | NS | |||
Vaccine × challenge∗age | NS | NS | NS | NS | NS | NS | NS | NS |
Superscripts for column headers refer to either VetScan ‘v’ or iStat ‘i’ devices that were used.
L: linear P value; Q: quadratic P value; NS: not statistically significant (P > 0.05).